Richard A. Colvin

2022

In 2022, Richard A. Colvin earned a total compensation of $1.4M as Chief Medical Officer at bluebird bio.

Compensation breakdown

Non-Equity Incentive Plan$216,000
Option Awards$374,297
Salary$467,639
Stock Awards$294,240
Other$12,600
Total$1,364,776

Colvin received $467.6K in salary, accounting for 34% of the total pay in 2022.

Colvin also received $216K in non-equity incentive plan, $374.3K in option awards, $294.2K in stock awards and $12.6K in other compensation.

Rankings

In 2022, Richard A. Colvin's compensation ranked 2,389th out of 5,505 executives tracked by ExecPay. In other words, Colvin earned more than 56.6% of executives.

ClassificationRankingPercentile
All
2,389
out of 5,505
57th
Division
Manufacturing
1,305
out of 2,984
56th
Major group
Chemicals And Allied Products
585
out of 1,339
56th
Industry group
Drugs
539
out of 1,242
57th
Industry
Biological Products, Except Diagnostic Substances
137
out of 287
52nd
Source: SEC filing on April 28, 2023.

Colvin's colleagues

We found three more compensation records of executives who worked with Richard A. Colvin at bluebird bio in 2022.

2022

Andrew Obenshain

bluebird bio

Chief Executive Officer

2022

Jason Cole

bluebird bio

Chief Strategy & Financial Officer former

2022

Thomas Klima

bluebird bio

Chief Commercial and Operating Officer

News

You may also like